The protein phosphatase calcineurin is known to be an essential intrac
ellular signal transducer involved in the TCR-mediated signal transduc
tion pathway and is the common target of the immunosuppressive drugs c
yclosporin A (CsA) and FK506. The catalytic subunit of calcineurin exi
sts in multiple isoforms, but their functional differences are not kno
wn. It has been assumed that the alpha isoform of calcineurin is the r
elevant isoform mediating TCR signaling, Recently, calcineurin alpha w
as knocked out in mice, but no defect in the TCR-mediated IL-2 product
ion was observed, suggesting that another isoform of calcineurin media
tes the TCR signal transduction pathway. We have generated specific po
lyclonal antibodies against the a and the beta 2 isoforms of calcineur
in and examined their distribution in murine tissues and immune cells
by immunohistochemical staining and Western blot analysis. We found th
at the beta 2 isoform of calcineurin is predominant in T and B lymphoc
ytes as well as in thymus compared to the cc isoform, suggesting that
the beta 2 isoform may play a key role in TCR signaling. Furthermore,
we observed that the two isoforms exhibit distinct expression patterns
in both kidney and thymus, indicating that the two isoforms of calcin
eurin have distinct cellular functions. Together, these findings raise
the possibility that the nephrotoxicity associated with CsA and FK506
can be reduced by designing novel inhibitors of caldineurin that targ
et specific isoforms of the enzyme. (C) 1997 Published by Elsevier Sci
ence Ltd.